Shoemaker Scott sold $34K of IIPR

Innovative Industrial Properties amended its $500M ATM program to include 9.25% Series B Preferred Stock. As of November 9, 2026, $336.9M remained available under the program, per the company's SEC filing.

INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On November 9, 2026, Innovative Industrial Properties, Inc. (the “Company”) and IIP Operating Partnership, LP entered into amendments (collectively, the “Amendments”) to each of the Company's existing equity distribution agreements with BTIG, LLC, Piper Sa

Innovative Industrial Properties Inc (IIPR) reported Q3 2026 earnings, highlighting record leasing activity but also challenges. The company regained properties from tenants like Parallel and PharmaCann, facing a 6-18 month re-leasing timeline. Non-recurring rent recoveries boosted AFFO by $0.15 per share. IIPR has 800,000 sq ft of vacancy, mostly in Florida. Security deposits for four of five tenants are exhausted.

Innovative Industrial Properties (IIPR) reported Q3 earnings, highlighting $14.3M in interest and other income. The company committed $545M to life sciences, expecting 26% of annualized income. It funded $111M for Alewife Park, with a 15.8% average interest rate. Leasing activity reached a record 874,000 sq ft. IIPR raised $54M from a preferred stock offering and extended its credit facility. Management sees opportunities in life science assets and cannabis real estate.

Innovative Industrial (IIPR) reported Q3 2026 earnings with AFFO per share up 7% to $1.96. The company committed $545M to life science investments, expected to generate ~15.8% interest. It also completed a $54M preferred stock offering. Leasing activity totaled 1.3M square feet year-to-date. The company sees opportunities in life science and cannabis sectors, with federal cannabis reform potentially benefiting operators.

Innovative Industrial Properties (IIPR) reported Q3 AFFO per share of $1.96, up 7% sequentially, driven by rent recoveries and new leasing. Life science commitments grew to $545M, with 874,000 sq ft leased since July, according to the company.